Dr. Tia Powell, M.D.


12/05/2017 - An op-ed by Tia Powell, M.D., outlines ethical issues associated with a “smart pill” that can track if a patient has taken medication. Dr. Powell is director of the Montefiore Einstein Center for Bioethics and the Dr. Shoshanah Trachtenberg Frackman Faculty Scholar in Biomedical Ethics at Einstein .

Dr. Phillip Castle, M.D.


11/27/2017 - Research led by Philip Castle, M.D., finds that women may be able to extend their screening interval for Pap tests depending on results of previous tests. Dr. Castle is a professor of epidemiology and population health.

Dr. Judith Wylie-Rosett, Ed.D., R.D.


07/06/2017 - U.S. News & World Report interviewed Judith Wylie-Rosett, EdD, RD to explain why diabetes is now more common in rural than urban areas of the United States.

Dr. Judith Wylie-Rosett, Ed.D., R.D.


10/20/2016 - The Montgomery County Sentinel interviewed Judith Wylie-Rosett, EdD, RD about the recent formation of a Nutrition Research Task Force (NRTF), which will focus on a developing a multidisciplinary integrated approach to nutritional research. The goal is to coordinate research addressing a wide range of illnesses including diabetes, cancer, obesity, and heart disease both within and outside of the National Institutes of Health.

Dr. Ilir Agalliu, MD, ScD

Assistant Professor

01/21/2016 - Dr. Ilir Agalliu and Dr. Robert Burk were recently interviewed by several media including NBC News, Newsweek, UPI and Medscape about their recent study on oral HPVs and risk of head and neck cancers, which was published at JAMA Oncology on January 21, 2016. In this study they found that when human papillomavirus (HPV)-16 is detected in peoples’ mouths, they are 22 times more likely than those without HPV-16 to develop oropharyngeal cancer (cancers of the middle part of the throat including the soft palate, the base of the tongue and the tonsils). This study is the first to demonstrate conclusively that HPV-16’s presence in the oral cavity precedes the development of oropharyngeal cancers. In addition, the researchers found for the first time that the presence of other types of oral HPVs—beta- and gamma-HPVs, which are usually detected in the skin—was also associated with the development of head and neck cancers, indicating a broader role for HPVs in causing these cancers than has been recognized to date. This study shows that using easily collected oral mouthwash samples may help in predicting people’s risk for developing head and neck cancers

NBC News




Dr. Thomas Rohan, MBBS, PhD, DHSc

Chairman and Professor

10/01/2015 - Each fall, The Estee Lauder Companies (ELC) launches a global breast cancer campaign to raise funds in support of breast cancer research. In the U.S., they kick off these activities by ringing the bell at the New York Stock Exchange (NYSE). Dr. Thomas Rohan participated in this event, joining William Lauder, along with ELC executives and employees, on the podium to ring the closing bell at NYSE on October 1.